B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 735.90M 748.90M 714.90M 677.70M 614.70M
Total Other Revenue -- -- -- -- --
Total Revenue 735.90M 748.90M 714.90M 677.70M 614.70M
Cost of Revenue 75.90M 83.10M 77.80M 72.90M 71.00M
Gross Profit 660.00M 665.80M 637.10M 604.80M 543.70M
SG&A Expenses 164.30M 154.10M 177.60M 144.40M 131.10M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 374.00M 340.70M 395.00M 321.40M 353.50M
Operating Income 361.90M 408.20M 319.90M 356.30M 261.20M
Income Before Tax 396.50M 388.60M 355.30M 398.60M 295.40M
Income Tax Expenses 95.20M 79.50M 77.20M 92.00M 78.30M
Earnings from Continuing Operations 301.30M 309.10M 278.10M 306.60M 217.10M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 301.30M 309.10M 278.10M 306.60M 217.10M
EBIT 361.90M 408.20M 319.90M 356.30M 261.20M
EBITDA 381.60M 427.30M 338.60M 371.30M 274.90M
EPS Basic 6.74 6.93 6.26 6.52 4.62
Normalized Basic EPS 5.63 6.31 5.01 5.23 3.58
EPS Diluted 6.18 6.39 5.85 6.17 4.35
Normalized Diluted EPS 5.17 5.82 4.68 4.94 3.38
Average Basic Shares Outstanding 44.70M 44.60M 44.40M 47.00M 47.00M
Average Diluted Shares Outstanding 48.70M 48.40M 47.50M 49.70M 49.80M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings